Drug Database
Back to search

Netherlands· NL-dba899fcf847

Fomepizole SERB 5 mg/ml, concentraat voor oplossing voor infusie

A fomepizole product containing fomepizolsulfaat, registered in Netherlands by SERB S.A.. The same ATC class is registered in 14 of our 19 countries.

ATC V03AB34

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFomepizole SERB 5 mg/ml, concentraat …ATCV03AB34REGISTER NO.NL-dba899fcf847PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fomepizolsulfaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fomepizole is registered in 14 of 19 countries.

Countries holding a registration under ATC V03AB34 (fomepizole), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search fomepizole products by name

Fomepizole · ATC V03AB34

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FOMEPIZOLSULFAAT
Manufacturer
SERB S.A.
Country
Netherlands (NL)
ATC code
V03AB34
ATC class
Fomepizole
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    26970

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for fomepizole.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fomepizole against other medicinesHow interaction checks work

Fomepizole · interactions on record

4 records

  • 4 severe

Most severe, free to view

  • EthanolB05XX04severe
  • EthanolV03AB16severe
  • EthanolV03AZ01severe
  • EthanolV07AB03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fomepizole in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fomepizole products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Fomepizole Ap-Hp
  • United Kingdom (Northern Ireland) · Fomepizole Waymade

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9e2e4f74-8ee4-4d85-a473-c49308ab1efc
GET /v1/drugs/9e2e4f74-8ee4-4d85-a473-c49308ab1efc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26970_smpc.pdf",
  "strength": null,
  "atc_label": "Fomepizole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26970",
  "excipients": [
    "NATRIUMCHLORIDE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "FOMEPIZOLSULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26970.pdf",
  "authorised_at": "2002/02/18",
  "procedure_number": "FR/H/0191/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "26970",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about fomepizole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console